Automated cell counters market to witness significant growth due to growing research efforts and increased awareness of preventive healthcare.

Market Research Future (MRFR) has published a cooked research report on the “Global Automated cell counters market” that contains information from 2018 to 2032. The Automated cell counters market is estimated to register a CAGR of 5.80% during the forecast period of 2023 to 2032.

Automated Cell Counters Market Highlights

The global automated cell counters market is accounted to register a CAGR of 5.80% during the forecast period and is estimated to reach USD 10.1 Billion by 2032.

The automated cell counters market offers advanced solutions for efficient and accurate cell analysis in research, clinical, and industrial settings. Utilizing technologies like image analysis and flow cytometry, these systems automate cell counting, viability assessment, and cell line monitoring. The market's growth is driven by demand for streamlined workflows and precise data in life sciences.

Key Players

MRFR recognizes the following companies as the key players in the global Automated cell counters market— Eppendorf, Thermo Fischer Scientific, Countstar Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Chemometec A/S, ALIGNEDGENETICS, Beckman Coulter, Inc. (Danaher), Nanoentek, Olympus Corporation, MERCK KGaA, Sysmex Corporation, Agilent Technologies, Inc., Abbott, Nexcelom Bioscience LLC and others

Segment Analysis

The global automated cell counters market has been segmented based Product Type, Application and End-use.

On the basis of product type, the market is segmented into fluorescence image-based cell counter, flow cytometer and coulter counter. The coulter counter segment dominated the market in 2022. When it comes to cell counting and sizing, Coulter counters are renowned for their remarkable accuracy and precision.

Based on application, the global automated cell counters market has been segmented into blood cells, cell lines, microbial cells and others. The blood cells segment dominated the market in 2022. Hematological diseases such as anemia, leukemia, lymphoma, and thrombocytopenia are on the rise globally.

Based on end-use, the global automated cell counters market has been segmented into includes pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories, research institutes and others. The hospitals category generated the most income in 2022. This is due to the growing demand for automated cell counters in clinical laboratories for blood analysis.

Explore In-depth Market Details [Table of Content, List of Figures, List of Tables] of Automated Cell Counters Market Research Report

Regional Analysis

The global automated cell counters market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Automated cell counters market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Automated cell counters market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Automated cell counters market comprises of Middle East, Africa, and Latin America.

The North America automated cell counters market dominated this market in 2022 (45.80%). In terms of biomedical research and development, North America is at the top of the list. Numerous pharmaceutical businesses, biotech firms, and academic research facilities for basic science study, clinical trials, and medication development are located in the area. The desire for more advanced cell counting equipment is fueled by this continual research activity.

Moreover, the Europe market has been persistently growing over the forecast period. Governments and healthcare organizations in Europe routinely launch public health initiatives that are geared toward disease prevention and early detection. These programs might involve cell counter automated testing to identify people at risk for various diseases.

From 2023 to 2032, the Automated cell counters market in Asia-Pacific is anticipated to experience the quickest CAGR growth. Asia Pacific has a huge and diverse population, spread over both secluded rural areas and heavily populated urban areas. The sheer size of the population creates a huge need for healthcare services, including diagnostic tools like automated cell counts, in order to address a variety of medical needs.

Furthermore, the rest of the world's automated cell counters market is divided into the Middle East, Africa, and Latin America. In Latin America, the automated cell counters market is witnessing steady growth. The adoption of advanced cell analysis technologies is increasing in research, diagnostics, and biopharmaceutical sectors. These automated systems streamline cell counting, viability testing, and data accuracy, catering to the region's expanding life sciences and healthcare needs.

Key Findings of the Study

• The global automated cell counters market is expected to reach USD 10.1 Billion by 2032, at a CAGR of 5.80% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market as the sheer size of the population generates a significant demand for healthcare services


• Based on application, the blood cells segment was attributed to holding the largest market in 2022.


• Eppendorf, Thermo Fischer Scientific, Countstar Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Chemometec A/S, ALIGNEDGENETICS, Beckman Coulter, Inc. (Danaher), Nanoentek, Olympus Corporation, MERCK KGaA, Sysmex Corporation, Agilent Technologies, Inc., Abbott, Nexcelom Bioscience LLC and others